COMMUNIQUÉS West-GlobeNewswire

VitalHub Introduces WellLinc Interoperability Solution

07/02/2018 - 13:00

TORONTO, Feb. 07, 2018 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV:VHI) announced today the introduction of WellLinc , a proprietary electronic health record (“EHR") interoperability solution [...]

Keryx Biopharmaceuticals Announces Fourth Quarter and Full Year 2017 Financial Results

07/02/2018 - 13:00

Fourth quarter 2017 total revenues of $18.7 million, including net U.S. Auryxia ® (ferric citrate) product sales of $17.3 million Full year 2017 total revenues of $60.6 million; net U.S. Auryxia product sales more than [...]

Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss Third Quarter Financial Results on February 12, 2018

07/02/2018 - 13:00

NORTHVALE, N.J., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCQB:ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent opioids and niche [...]

Akcea Completes Enrollment in Phase 2b Study of AKCEA-APO(a)-LRx

07/02/2018 - 13:00

CAMBRIDGE, Mass., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA ), today announced it had completed enrollment of a Phase 2b clinical study of investigational drug AKCEA-APO(a)-L Rx . Akcea is [...]

Humanigen Appoints Rainer Boehm, M.D., to Board of Directors

07/02/2018 - 13:00

BRISBANE, Calif., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Humanigen, Inc. (OTCQB:HGEN), a biopharmaceutical company pursuing cutting-edge science to develop its proprietary monoclonal antibodies for immunotherapy and oncology [...]

Coloplast acquires IncoCare Gunhild Vieler GmbH

07/02/2018 - 12:31

Coloplast A/S acquires the German direct-to-consumer homecare company IncoCare Gunhild Vieler GmbH (IncoCare) to further strengthen its position in Germany. Together, Coloplast and IncoCare will bring innovative [...]

Epizyme to Participate in Leerink Partners 7th Annual Global Healthcare Conference

07/02/2018 - 12:30

CAMBRIDGE, Mass., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Epizyme, Inc. (NASDAQ: EPZM ), a clinical-stage biopharmaceutical company creating novel epigenetic therapies, today announced that management will participate in a [...]

AnaptysBio To Present Data from ANB020 Phase 2a Atopic Dermatitis Trial at AAD Annual Meeting

07/02/2018 - 12:30

SAN DIEGO, Feb. 07, 2018 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB ), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation [...]

Clementia to Participate in Leerink Partners 7th Annual Global Healthcare Conference

07/02/2018 - 12:30

MONTREAL, Quebec, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (NASDAQ: CMTA ), a clinical-stage biopharmaceutical company innovating new treatments for people with ultra-rare bone disorders and [...]

Clementia Annonce qu’elle Participera à la 7e Conférence Annuelle Mondiale sur les Soins de Santé Leerink Partners (« Leerink Partners 7th Annual Global Healthcare Conference »)

07/02/2018 - 12:30

MONTRÉAL, Québec, 07 févr. 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (NASDAQ: CMTA ), une société biopharmaceutique au stade clinique proposant des traitements novateurs pour les personnes atteintes de [...]

Natus Medical Announces Fourth Quarter and Full Year 2017 Financial Results

07/02/2018 - 12:10

Reports record fourth quarter revenue of $131.4 million and full year revenue of $501.0 million Reports fourth quarter GAAP earnings (loss) per share of $(0.22) and non-GAAP of $0.42 PLEASANTON, Calif., Feb. 07, 2018 ( [...]

ViaDerma, Inc. Announced the Dismissal of a Lawsuit Against Them in US District Federal Court

07/02/2018 - 11:00

LOS ANGELES, Feb. 07, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink:VDRM), recently announced the complaint filed by Steven J. Keough in a South Dakota Federal Court, has been dismissed without prejudice. The [...]

Sanofi Delivers 2017 Business EPS(1) in line with Guidance

07/02/2018 - 09:45

Paris, February 7, 2018 Sanofi Delivers 2017 Business EPS (1) in line with Guidance Q4 2017 Change Change at CER Change at CER/CS (2) 2017 Change Change at CER Change at CER/CS (2) IFRS net sales reported €8,691m -2.0 [...]

Sanofi : BNPA des activités(1) de 2017 en ligne avec les perspectives annoncées

07/02/2018 - 09:45

Paris, le 7 février 2018 BNPA des activités (1) de 2017 en ligne avec les perspectives annoncées T4 2017 Variation Var. à TCC Var. à TCC/PC (2) 2017 Variation Var. à TCC Var. à TCC/PC (2) Chiffre d'affaires net IFRS [...]

Saniona AB: Saniona Completes Recruitment in Phase I study with new Tesomet tablet

07/02/2018 - 09:31

PRESS RELEASE February 7, 2018 Saniona, a leading biotech company in the field of ion channels, today announced that it has completed the recruitment of participants into the Phase 1 pharmacokinetic study of Tesomet [...]

Group financial statement for 2017

07/02/2018 - 07:59

Solid 2017. Good momentum set to continue Solid year with 4% organic sales growth (Q4: +4%): Household Care +1%, Food & Beverages +9%, Bioenergy +11%, Agriculture & Feed -3%, Technical & Pharma +2%. EBIT [...]

Annual Report 2017 for H. Lundbeck A/S

07/02/2018 - 07:53

Valby, Denmark, 2018-02-07 07:53 CET (GLOBE NEWSWIRE) -- Annual Report 2017 for H. Lundbeck A/S.

Lundbeck delivers its best financial results following 10% revenue growth and 117% growth in net profit

07/02/2018 - 07:48

Valby, Denmark, 2018-02-07 07:48 CET (GLOBE NEWSWIRE) -- HIGHLIGHTS Revenue reached DKK 17,234 million in 2017 representing an increase of 10% (12% in local currencies) compared to 2016 Revenue of Abilify Maintena ® [...]

Zealand reports royalty revenue for the fourth quarter of 2017

07/02/2018 - 07:34

Company announcement - No. 7/2018 Zealand reports royalty revenue for the fourth quarter of 2017 Zealand reports royalty revenue of DKK 11.3 million/USD 1.8 million for Q4 2017 The revenue is based on total net sales of [...]